Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis

Clinical trial NCT01257386 · COMPLETED

Trial details

NCT number: NCT01257386
Sponsor: Tillotts Pharma AG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Active Ulcerative Colitis

Start date: 2010-11-01
Primary completion: 2012-08-01
Enrollment: 251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.